Novel insights of HBV RNA in hepatitis B virus pathogenesis and clinical application

Abstract

Hepatitis B virus (HBV) infection is still a severe health problem in the world, and chronic hepatitis B (CHB) is the major cause of serious HBV-related complications, including fibrosis, hepatic failure, and hepatocellular carcinoma. It is difficult for CHB patients to achieve complete cure as the currently available antiviral drugs can hardly eradicate covalently closed circular DNA (cccDNA) in the infected liver. Since detecting intrahepatic cccDNA needs invasive procedure, it is urgent to find a noninvasive indicator to reflect the activity of cccDNA. Recently, growing numbers of studies have indicated that serum HBV RNA could be regarded as a new biomarker for CHB activity. In order to illustrate the molecular biology and clinical characteristics of HBV RNA, we systematically reviewed the latest research to summarize the role of HBV RNA in HBV replication and pathogenicity, and to better estimate its potential function as a remarkable biomarker in clinical application. Meanwhile, we will also point out the deficiencies of current research, and discuss the future direction of HBV RNA study.

Keywords

Hepatitis B virus / pregenomic RNA / serum biomarker / chronic hepatitis B / hepatocellular carcinoma / cirrhosis

References

[1] Chisari FV,Wieland SF.Pathogenesis of hepatitis B virus infection..Pathol Biol (Paris)2010;58:258-66 PMCID:PMC2888709

[2] Chan SL,Qin S.Infection and cancer: the case of hepatitis B..J Clin Oncol2016;34:83-90

[3] Hou JL.The guideline of prevention and treatment forchronic hepatitis B: a 2015 update..Chin J Hepato (Zhonghua GanZang Bing Za Zhi)2015;23:888-905(in Chinese)

[4] Quasdorff M.Control of hepatitis B virus at the level of transcription..J Viral Hepat2010;17:527-36

[5] Stahl M,Nassal M.Chaperones activate hepadnavirus reverse transcriptase by transiently exposing a C-proximal region in the terminal protein domain that contributes to epsilon RNA binding..J Virol2007;81:13354-64 PMCID:PMC2168843

[6] Wang J,Li G,Meng Z.Relationship between serum HBV-RNA levels and intrahepatic viral as well as histologic activity markers in entecavir-treated patients..J Hepatol2018;68:16-24

[7] Halgand B,Rivière L,Sebagh M.Hepatitis B virus pregenomic RNA in hepatocellular carcinoma: a nosological and prognostic determinant..Hepatology2018;67:86-96

[8] Wang J,Huang X,Chen X.Serum hepatitis B virus RNA is encapsidated pregenome RNA that may be associated with persistence of viral infection and rebound..J Hepatol2016;65:700-10

[9] Hong X,Guo H.Epigenetic regulation of hepatitis B virus covalently closed circular DNA: implications for epigenetic therapy against chronic hepatitis B..Hepatology2017;66:2066-77 PMCID:PMC5696023

[10] Block TM,Guo JT.Molecular virology of hepatitis B virus for clinicians..Clin Liver Dis2007;11:685-706 PMCID:PMC2144742

[11] Jones SA.Hepatitis B virus reverse transcriptase: diverse functions as classical and emerging targets for antiviral intervention..Emerg Microbes Infect2013;2:e56 PMCID:PMC3820986

[12] Stahl M,Nassal M.Chaperones activate hepadnavirus reverse transcriptase by transiently exposing a C-proximal region in the terminal protein domain that contributes to epsilon RNA binding..J Virol2007;81:13354-64 PMCID:PMC2168843

[13] Prange R.Host factors involved in hepatitis B virus maturation, assembly, and egress..Med Microbiol Immunol2012;201:449-61

[14] Wang S,Yan X,Wang Y.Loss of microRNA 122 expression in patients with hepatitis B enhances hepatitis B virus replication through cyclin G(1) -modulated P53 activity..Hepatology2012;55:730-41

[15] Deng M,Hu J,Chen M.Hepatitis B virus mRNAs functionally sequester let-7a and enhance hepatocellular carcinoma..Cancer Lett2016;383:62-72

[16] Li C,Wang S,Hao J.Hepatitis B virus mRNA-mediated miR-122 inhibition upregulates PTTG1-binding protein, which promotes hepatocellular carcinoma tumor growth and cell invasion..J Virol2013;87:2193-205 PMCID:PMC3571498

[17] Wang Y,Ji X,Zhang Y.Hepatitis B viral RNA directly mediates down-regulation of the tumor suppressor microRNA miR-15a/miR-16-1 in hepatocytes..J Biol Chem2013;288:18484-93 PMCID:PMC3689990

[18] Yang X,Sun H,Hu Y.Hepatitis B virus-encoded microRNA controls viral replication..J Virol2017;91:01919-16 PMCID:PMC5411615

[19] Yin S,Zhang H,Hao Y.Differential TGF-β pathway targeting by miR-122 in humans and mice affects liver cancer metastasis..Nat Commun2016;7:11012 PMCID:PMC4802055

[20] Sato S,Kameyama T,Ishida Y.The RNA sensor RIG-I dually functions as an innate sensor and direct antiviral factor for hepatitis B virus..Immunity.2015;42:123-32

[21] Breitkreutz R,Lee M,Tokus M.Hepatitis B virus nucleic acids circulating in the blood: distinct patterns in HBs carriers with hepatocellular carcinoma..Ann N Y Acad Sci2001;945:195-206

[22] Hilger C,Zentgraf H.Diversity of hepatitis B virus X gene-related transcripts in hepatocellular carcinoma: a novel polyadenylation site on viral DNA..J Virol1991;65:4284-91 PMCID:PMC248866

[23] Takata A,Ohno M,Yoshikawa T.Mutual antagonism between hepatitis B viral mRNA and host microRNA let-7..Sci Rep2016;6:23237 PMCID:PMC4793232

[24] Giersch K,Volz T,Lutgehetmann M.Serum HBV pgRNA as a clinical marker for cccDNA activity..J Hepatol2017;66:460-2

[25] Sarin SK,Lau GK,Chan HL.Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update..Hepatol Int2016;10:1-98 PMCID:PMC4722087

[26] Lampertico P,Berg T,Janssen HLA.EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection..J Hepatol2017;67:370-98

[27] Terrault NA,Chang KM,Jonas MM.AASLD guidelines for treatment of chronic hepatitis B..Hepatology2016;63:261-83 PMCID:PMC5987259

[28] Jansen L,van Dort KA,Reesink HW.Hepatitis B virus pregenomic RNA is present in virions in plasma and is associated with a response to pegylated interferon Alfa-2a and uucleos(t)ide analogues..J Infect Dis2016;213:224-32

[29] van Bommel F,Mysickova A,Kruger DH.Serum hepatitis B virus RNA levels as an early predictor of hepatitis B envelope antigen seroconversion during treatment with polymerase inhibitors..Hepatology2015;61:66-76

[30] van Bommel F,Krauel A,Pavlovic V.Serum HBV RNA as a predictor of peginterferon Alfa-2a (40KD) response in patients with HBeAg-positive chronic hepatitis B..J Infect Dis2018;218:1066-74

[31] Huang YW,Tsuge M,Wang TC.On-treatment low serum HBV RNA level predicts initial virological response in chronic hepatitis B patients receiving nucleoside analogue therapy..Antivir Ther2015;20:369-75

[32] Wang J,Huang H,Niu J.Reply to: “Serum HBV pgRNA as a clinical marker for cccDNA activity”: Consistent loss of serum HBV RNA might predict the “para-functional cure” of chronic hepatitis B..J Hepatol2017;66:462-3

[33] Tsuge M,Imamura M,Miki D.Serum HBV RNA and HBeAg are useful markers for the safe discontinuation of nucleotide analogue treatments in chronic hepatitis B patients..J Gastroenterol2013;48:1188-204

[34] Kock J,Galle P.Hepatitis B virus nucleic acids associated with human peripheral blood mononuclear cells do not originate from replicating virus..Hepatology1996;23:405-13

[35] Su Q,Chang TE,Hennig H.Circulating hepatitis B virus nucleic acids in chronic infection : representation of differently polyadenylated viral transcripts during progression to nonreplicative stages..Clin Cancer Res2001;7:2005-15

[36] Hacker HJ,Tokus M,Schroder CH.Patterns of circulating hepatitis B virus serum nucleic acids during lamivudine therapy..Ann N Y Acad Sci2004;1022:271-81

[37] Kairat A,Zhou G,Edler L.Truncated hepatitis B virus RNA in human hepatocellular carcinoma: its representation in patients with advancing age..Intervirology1999;42:228-37